Latest News Releases From The Newsroom
Mellissa Campbell Duru Named Division of Corporation Finance’s Deputy Director for Legal and Regulatory Policy
May 19th, 2023
FOR IMMEDIATE RELEASE 2023-96 Washington D.C. / CRWE PRESS RELEASE / May 19, 2023 - The Securities and Exchange Commission today announced that Mellissa Campbell Duru has been named Deputy Director for Legal and Regulatory Policy in t. Read more
Initiations and Price Targets: Apollo Global, The Toro Company, Xencor, Intuitive Machines, and Calix Receive Ratings and Outlooks from Analysts
May 19th, 2023
Apollo Global Management, Inc. (NYSE: APO) has been initiated with a Buy rating and a price target of $80 by Citigroup, indicating a positive outlook for the company. In the current trading session, $APO is being traded at $63.68, reflecting a gai. Read more
Breaking News: WISeKey-FOSSA WISeSat-Ready Satellite Launch, Stereotaxis-Abbott Collaboration and Dell's Price Target Boost Shake Up Tech Market
May 19th, 2023
WISeKey International Holding Ltd (Nasdaq: WKEY) made an exciting announcement today, revealing a new collaboration with FOSSA Systems to launch a series of WISeSat-Ready FOSSA powered satellites in partnership with SpaceX. This joint effort. Read more
RBC Bearings Beats Expectations, Hologic Receives FDA Clearance, Cantor Fitzgerald Bullish on Bitfarms
May 19th, 2023
RBC Bearings Incorporated (NYSE: RBC) has released its fourth-quarter fiscal 2023 earnings report, surpassing consensus expectations. The company reported an EPS of $2.13, exceeding the consensus estimate of $1.99. In pre-market, $RBC is currently. Read more
CureVac's Patent Litigation Moves to Virginia, Ambrx Biopharma Receives Overweight Rating, Legend Biotech Gets Price Target Boost
May 19th, 2023
CureVac N.V. (Nasdaq: CVAC) has made an important announcement regarding the ongoing patent litigation initiated by Pfizer (NYSE: PFE)/BioNTech (Nasdaq: BNTX). CureVac's motion to transfer the litigation from the federal district court of Massachuset. Read more
Deere & Company Surpasses Q2 Expectations, Foot Locker Falls Short, and Intercept Pharmaceuticals Stock Halted Amid FDA Review
May 19th, 2023
Deere & Company (NYSE: DE) has released its second-quarter fiscal 2023 earnings per share (EPS) report, surpassing consensus expectations. The company reported an EPS of $9.65, exceeding the consensus estimate of $8.59. John C. May, the chairman a. Read more
Price Target Updates: Walmart, Globant, EyePoint Pharmaceuticals, TE Connectivity, ZTO Express, and Grab Holdings Experience Changes
May 19th, 2023
Several companies have seen changes in their price targets and ratings by various advisory groups and financial institutions. Here are the details: Walmart Inc. (NYSE: WMT) has received price target increases from different sources. Telsey Advisor. Read more
Citigroup Initiates Coverage on Major Investment Firms: Insights on BlackRock, Blackstone, Blue Owl, KKR & Co, and Carlyle Group
May 19th, 2023
Citigroup has initiated coverage on several major investment firms with favorable recommendations and price targets. BlackRock Inc. (NYSE: BLK) has been initiated with a Buy rating and a price target of $750. In pre-market trading, the stock is cu. Read more
Flowers Foods Adjusts Outlook, Cavco Industries Surpasses Expectations, OncoSec Medical Closes Offering
May 18th, 2023
Flowers Foods, Inc. (NYSE: FLO) has reported adjusted earnings per share (EPS) of $0.38 for the first quarter of fiscal 2023, meeting the consensus estimate. However, due to a slow start to the year and lower-than-expected branded retail sales result. Read more
Ross Stores Exceeds Q1 Expectations, Pfizer's RSV Vaccine Candidate Gains FDA Committee Support, Lucy Scientific Partners with TheraPsil for Psilocybin Access
May 18th, 2023
Ross Stores, Inc. (Nasdaq: ROST) has reported first-quarter fiscal 2023 earnings per share (EPS) of $1.09, surpassing the consensus estimate of $1.06. However, in after-hours trading, $ROST is experiencing a slight decline, currently trading at $105.. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025Earnings Preview: Credo Technology, MongoDB, and Hafnia in Focus
November 30th, 2025
Member Login